| Literature DB >> 19002847 |
Yanjie You1, Xiaochang Xue, Meng Li, Xin Qin, Cun Zhang, Weihua Wang, Changli Giang, Shouzhen Wu, Yan Liu, Wenhua Zhu, Yonggang Ran, Zhen Zhang, Wei Han, Yingqi Zhang.
Abstract
Tumor growth and metastasis depend on vessel formation, and inhibition of angiogenesis of tumor by production of anti-angiogenic drugs should be a promising approach for cancer therapy. Tumstatin is an angiogenesis inhibitor. The anti-angiogenic activity of tumstatin is localized to the 54-132 amino acids. The gene fragment encoding amino acids 45-132 of tumstatin (tum-5) was subcloned into pcDNA3.1 (pcDNA-tum5). Tum-5 protein could be expressed and secreted in CHO cells after transfection. The conditioned medium (containing tum-5 protein) from the transfectant has an anti-angiogenic effect on HUVEC cells in vitro. The anti-tumor effect of pcDNA-tum5 on mice bearing S180 tumors was evaluated. The results showed that pcDNA-tum-5 has a significant inhibition activity in the growth of the tumors. This study suggests that the gene delivery of tum-5 may be an effective strategy for cancer therapy.Entities:
Year: 2007 PMID: 19002847 PMCID: PMC2259260 DOI: 10.1007/s10616-007-9117-9
Source DB: PubMed Journal: Cytotechnology ISSN: 0920-9069 Impact factor: 2.058